Workflow
Longevity
icon
Search documents
Amino Innovations Expands Market Presence Alongside Global Health Leaders Gary Brecka, Lara Trump, and Tito Ortiz at Leading Biohacking and Longevity Summits
Thenewswire· 2025-10-10 12:30
Core Insights - Pangea Natural Foods Inc. is expanding its market presence through its subsidiary Amino Innovations by sponsoring and exhibiting at three major health and longevity events in October 2025 [1] Group 1: Event Participation - Amino Innovations is sponsoring and exhibiting at the MoreLife Biohacking Summit on October 11-12, 2025, which focuses on health optimization and features notable speakers from various fields [2] - Earlier in October, Amino Innovations participated in the Healthspan Summit, a key forum for cellular medicine and regenerative health, connecting with leading clinicians and investors [3] - Amino Innovations will also be featured at Disrupt Business 2025 from October 17-19, 2025, where Co-Founder Justin Kirkland will discuss needle-free peptide delivery systems [5] Group 2: Product Showcase - The participation in both summits allowed Amino Innovations to showcase its non-injectable peptide products, generating strong interest from health professionals and performance enthusiasts [4] - Live demonstrations at these events highlighted the convenience and efficacy of Amino's delivery formats, reinforcing the company's mission to innovate in peptide therapies [4] Group 3: Company Overview - Pangea Natural Foods Inc. specializes in clean-label foods and wellness products, with Amino Innovations focusing on advanced, needle-free peptide therapies that support recovery and cognitive function [6]
Steve Aoki on Launching His Venture Platform, Aoki Labs
Bloomberg Television· 2025-10-08 22:44
Investment Strategy & Focus - Steve Aoki is launching Aoki Labs, a venture platform focused on well-being and innovation [2] - Aoki has been investing for approximately 15 years, now with a structured team for due diligence [3] - Fund one is closed with investments allocated into promising companies [5] - Investment focus is on health and longevity, with personal testing influencing investment decisions [7] - The fund invests in both companies known for a while and those discovered through due diligence [6] Investment Opportunities & Due Diligence - Early investments included SpaceX, Spotify, Uber, and Pinterest [4] - The team conducts proper due diligence, involving multiple investors [3][4] - Opportunities arise from both inbound pitches and proactive sourcing [5] - The fund invests in companies that align with personal use and observation of market performance, particularly in the entertainment sector and B2C models [8] Longevity & Healthcare Investments - Investments include companies focused on blood work analysis and biological age assessment [7] - Super Power, a company offering blood work analysis on 100 biomarkers, provides tests for $200, a significant reduction from the previous cost of $100,000 [10] - The goal is to make health analysis accessible and affordable for the general public [13] AI Investments - Invested in Music I, an AI company focused on mixing and mastering music [14] - Actively and thoughtfully exploring further investments in the AI space [13][14]
Targeting the Best in AI, Wellness, Longevity with Veteran Dealmaker Harry You – Initiation Report
Yahoo Finance· 2025-10-06 16:58
Group 1 - The core focus of Berto Acquisition Corp. (TACO) is on growth-stage businesses in the AI, wellness, and longevity sectors, leveraging the current market trends [1][2] - TACO's management team has identified these thematic areas as particularly attractive, indicating a strategic approach to target selection [2] - The executive team possesses extensive deal-making experience and operational expertise, aiming to build momentum post-merger [3] Group 2 - TACO has demonstrated significantly low redemption rates in past SPAC transactions, with rates between 0% and 3%, compared to the industry average of approximately 68% [4] - This low redemption rate reflects high market confidence in TACO's ability to create value for investors and partners [4]
X @The Wall Street Journal
Health & Longevity - The study focuses on "super agers" who maintain health at 85 years and above [1] - Dr Eric Topol, a 70-year-old cardiologist, shares daily habits for longevity [1] - The advice shared is being followed by Dr Topol himself [1]
X @Forbes
Forbes· 2025-10-04 18:00
Longer Leash On Life: Inside The Dog Longevity Startuphttps://t.co/jz63bFj0Jhhttps://t.co/jz63bFj0Jh ...
X @Solana
Solana· 2025-10-04 01:08
RT Solana DeSci (@SolanaDeSci)Longevity isn’t just a dream — it’s becoming a data-driven reality.@vita_dao is putting science and community at the center of that missionDrop a 🧬 below if you believe in the mission https://t.co/2Efx8LQvW7 ...
X @Forbes
Forbes· 2025-10-03 22:00
Company Overview - The article discusses a startup focused on dog longevity [1] Industry Focus - The company operates within the emerging field of longevity research, specifically targeting canine health [1]
X @Forbes
Forbes· 2025-10-03 03:15
Longer Leash On Life: Inside The Dog Longevity Startuphttps://t.co/jz63bFj0Jhhttps://t.co/jz63bFj0Jh ...
BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants
Globenewswire· 2025-10-02 20:39
Core Insights - The European Wellness Biomedical Group (EWBG) emphasizes that true longevity is achieved through cellular regeneration rather than organ transplantation, focusing on healthspan over lifespan [1][3][17] - Prof. Mike Chan's recent publications include the Human Cytology Atlas, which maps over 400 distinct human cell types, and a study on organ aging, highlighting the varying rates at which different organs age [1][11][24] Company Developments - EWBG has published significant scientific contributions, including the Human Cytology Atlas and a peer-reviewed study on organ aging, reinforcing its position in the field of regenerative medicine [1][10][24] - The company is involved in global collaborations, such as working with the Chinese government on autism therapies and ongoing research with Heidelberg University in Germany and Switzerland [14][24][25] Industry Trends - The conversation around longevity is shifting from organ transplantation to cellular regeneration, with a focus on targeted therapies that address the cellular mechanisms of aging [6][12][17] - Prof. Chan advocates for precision medicine that tailors interventions to individual cellular profiles, aiming to extend healthspan rather than merely increasing lifespan [13][21]
X @Forbes
Forbes· 2025-10-01 18:30
Longer Leash On Life: Inside The Dog Longevity Startuphttps://t.co/jz63bFj0Jhhttps://t.co/jz63bFj0Jh ...